![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 35/00 | (2006.01) |
C07K 14/70521 | (2013.01) | ||
A61K 35/17 | (2015.01) | ||
C07K 14/7158 | (2013.01) | ||
C12N 15/113 | (2013.01) | ||
A61K 35/28 | (2015.01) | ||
C12N 15/87 | (2013.01) | ||
A61K 38/00 | (2006.01) | ||
C07H 21/04 | (2006.01) | ||
C12N2310/20 | (2017.05) | ||
C07K 14/725 | (2006.01) | ||
A61K 35/17 | (2013.01) | ||
C07K 14/705 | (2006.01) | ||
C07K 14/4718 | (2013.01) | ||
C07K 14/715 | (2006.01) | ||
C07K 14/7051 | (2013.01) | ||
C12N 9/22 | (2006.01) | ||
C12N 5/0636 | (2013.01) | ||
C12N 9/96 | (2006.01) | ||
C12N2510/00 | (2013.01) | ||
C12N 15/87 | (2006.01) | ||
C07K 14/70503 | (2013.01) | ||
C12N 15/90 | (2006.01) | ||
C12N 15/907 | (2013.01) | ||
C07K 14/47 | (2006.01) | ||
C12N 9/22 | (2013.01) | ||
C12N 5/0783 | (2010.01) | ||
C12N 9/96 | (2013.01) | ||
C12N 15/113 | (2010.01) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 3328399 |
(13) | Kind of document | T |
(96) | European patent application number | 16833645.1 |
Date of filing the European patent application | 2016-07-29 | |
(97) | Date of publication of the European application | 2018-06-06 |
(45) | Date of publication and mention of the grant of the patent | 2023-12-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/044858 |
Date | 2016-07-29 |
(87) | Number | WO 2017/023803 |
Date | 2017-02-09 |
(30) | Number | Date | Country code |
201562199905 P | 2015-07-31 | US | |
201562232983 P | 2015-09-25 | US | |
201662286206 P | 2016-01-22 | US | |
201662295670 P | 2016-02-16 | US | |
201662330464 P | 2016-05-02 | US | |
201662360245 P | 2016-07-08 | US |
(72) |
MORIARITY, Branden , US
WEBBER, Beau , US
MCIVOR, Scott, R. , US
LARGAESPADA, David , US
CHOUDHRY, Modassir , US
ROSENBERG, Steven A. , US
RESTIFO, Nicholas P. , US
PALMER, Douglas C. , US
|
(73) |
Regents of the University of Minnesota ,
600 McNamara Alumni Center
200 Oak Street SE, Minneapolis, MN 55455-2020,
US
Intima Bioscience, Inc. , 3 Columbus Circle, New York, New York 10019, US The United States of America, as represented by the Secretary, Department of Health and Human Services , 6011 Executive Boulevard, Suite 325, MSC 7660, Bethesda, MD 20892-7660, US |
(54) | MODIFIED CELLS AND METHODS OF THERAPY |
MODIFIED CELLS AND METHODS OF THERAPY |